Withaferin A-stimulated Ca2+ entry, ceramide formation and suicidal death of erythrocytes

Toxicology in Vitro

Volumn 27, Issue 1, 2013, Pages 52-58

  Jilani, Kashif ^a   Lupescu, Adrian ^a   Zbidah, Mohanad ^a   Shaik, Nazneen ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Calcium; Cell volume; Eryptosis; Phosphatidylserine; Withaferin A

Indexed keywords

CERAMIDE; HEMOGLOBIN; LIPOCORTIN 5; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE; WITHAFERIN A; ANTINEOPLASTIC AGENT; CALCIUM; WITHANOLIDE;

ARTICLE; BINDING KINETICS; CALCIUM TRANSPORT; CELL DEATH; CELL MEMBRANE; CELL SUBPOPULATION; CELL SURFACE; CELL VOLUME; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ERYTHROCYTE; EXTRACELLULAR CALCIUM; HEMOLYSIS; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; OXIDATIVE STRESS; PROTEIN SECRETION; APOPTOSIS; METABOLISM;

WITHANIA SOMNIFERA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CALCIUM; CERAMIDES; ERYTHROCYTES; HEMOLYSIS; OXIDATIVE STRESS; WITHANOLIDES;

EID: 84869396808     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2012.09.004     Document Type: Article

References (71)

1. Agalakova N.I., Gusev G.P. Fluoride-induced death of rat erythrocytes in vitro. Toxicol. In Vitro 2011, 25:1609-1618.
2. Arboleda G., Huang T.J., Waters C., Verkhratsky A., Fernyhough P., Gibson R.M. Insulin-like growth factor-1-dependent maintenance of neuronal metabolism through the phosphatidylinositol 3-kinase-Akt pathway is inhibited by C2-ceramide in CAD cells. Eur. J. Neurosci. 2007, 25:3030-3038.
3. Bargagna-Mohan P., Hamza A., Kim Y.E., Khuan Abby H.Y., Mor-Vaknin N., Wendschlag N., Liu J., Evans R.M., Markovitz D.M., Zhan C.G., Kim K.B., Mohan R. The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin. Chem. Biol. 2007, 14:623-634.
4. Becker K.A., Grassme H., Zhang Y., Gulbins E. Ceramide in Pseudomonas aeruginosa infections and cystic fibrosis. Cell. Physiol. Biochem. 2010, 26:57-66.
5. Bhavsar S.K., Bobbala D., Xuan N.T., Foller M., Lang F. Stimulation of suicidal erythrocyte death by alpha-lipoic acid. Cell. Physiol. Biochem. 2010, 26:859-868.
6. Bhavsar S.K., Eberhard M., Bobbala D., Lang F. Monensin induced suicidal erythrocyte death. Cell. Physiol. Biochem. 2010, 25:745-752.
7. Bhavsar S.K., Gu S., Bobbala D., Lang F. Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death. Cell. Physiol. Biochem. 2011, 27:547-556.
8. Bobbala D., Alesutan I., Foller M., Huber S.M., Lang F. Effect of anandamide in Plasmodium Berghei-infected mice. Cell. Physiol. Biochem. 2010, 26:355-362.
9. Borst O., Abed M., Alesutan I., Towhid S.T., Qadri S.M., Foller M., Gawaz M., Lang F. Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX 2011, Am. J. Physiol. Cell Physiol.
10. Calderon-Salinas J.V., Munoz-Reyes E.G., Guerrero-Romero J.F., Rodriguez-Moran M., Bracho-Riquelme R.L., Carrera-Gracia M.A., Quintanar-Escorza M.A. Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease. Mol Cell Biochem. 2011, 357(1-2):171-179.
11. Choi M.J., Park E.J., Min K.J., Park J.W., Kwon T.K. Endoplasmic reticulum stress mediates withaferin A-induced apoptosis in human renal carcinoma cells. Toxicol. In Vitro 2011, 25:692-698.
12. Chung S.M., Bae O.N., Lim K.M., Noh J.Y., Lee M.Y., Jung Y.S., Chung J.H. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler. Thromb. Vasc. Biol. 2007, 27:414-421.
13. de la Monte S.M. Insulin resistance and Alzheimer's disease. BMB Rep. 2009, 42:475-481.
14. Devi P.U. Withania somnifera Dunal (Ashwagandha): potential plant source of a promising drug for cancer chemotherapy and radiosensitization. Indian J. Exp. Biol. 1996, 34:927-932.
15. Dhami R., He X., Schuchman E.H. Acid sphingomyelinase deficiency attenuates bleomycin-induced lung inflammation and fibrosis in mice. Cell. Physiol. Biochem. 2010, 26:749-760.
16. Eberhard M., Ferlinz K., Alizzi K., Cacciato P.M., Faggio C., Foller M., Lang F. FTY720-induced suicidal erythrocyte death. Cell. Physiol. Biochem. 2010, 26:761-766.
17. Felder K.M., Hoelzle K., Ritzmann M., Kilchling T., Schiele D., Heinritzi K., Groebel K., Hoelzle L.E. Hemotrophic mycoplasmas induce programmed cell death in red blood cells. Cell. Physiol. Biochem. 2011, 27:557-564.
18. Foller M., Feil S., Ghoreschi K., Koka S., Gerling A., Thunemann M., Hofmann F., Schuler B., Vogel J., Pichler B., Kasinathan R.S., Nicolay J.P., Huber S.M., Lang F., Feil R. Anemia and splenomegaly in cGKI-deficient mice. Proc. Natl. Acad. Sci. USA 2008, 105:6771-6776.
19. Foller M., Kasinathan R.S., Koka S., Lang C., Shumilina E., Birnbaumer L., Lang F., Huber S.M. TRPC6 contributes to the Ca(2+) leak of human erythrocytes. Cell. Physiol. Biochem. 2008, 21:183-192.
20. Foller M., Sopjani M., Koka S., Gu S., Mahmud H., Wang K., Floride E., Schleicher E., Schulz E., Munzel T., Lang F. Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J. 2009, 23:1072-1080.
21. Gao M., Cheung K.L., Lau I.P., Yu W.S., Fung K.P., Yu B., Loo J.F., Kong S.K. Polyphyllin D induces apoptosis in human erythrocytes through Ca(2+) rise and membrane permeabilization. Arch. Toxicol. 2012, 85:741-752.
22. Gatidis S., Zelenak C., Fajol A., Lang E., Jilani K., Michael D., Qadri S.M., Lang F. P38 MAPK activation and function following osmotic shock of erythrocytes. Cell. Physiol. Biochem. 2011, 28:1279-1286.
23. Ghashghaeinia M., Toulany M., Saki M., Bobbala D., Fehrenbacher B., Rupec R., Rodemann H.P., Ghoreschi K., Rocken M., Schaller M., Lang F., Wieder T. The NFkB pathway inhibitors bay 11-7082 and parthenolide induce programmed cell death in anucleated erythrocytes. Cell. Physiol. Biochem. 2011, 27:45-54.
24. Grover A., Shandilya A., Bisaria V.S., Sundar D. Probing the anticancer mechanism of prospective herbal drug withaferin A on mammals: a case study on human and bovine proteasomes. BMC Genomics 2010, 11(Suppl. 4):S15.
25. Grover A., Shandilya A., Punetha A., Bisaria V.S., Sundar D. Inhibition of the NEMO/IKKbeta association complex formation, a novel mechanism associated with the NF-kappaB activation suppression by Withania somnifera's key metabolite withaferin A. BMC Genomics 2010, 11(Suppl. 4):S25.
26. Hahm E.R., Lee J., Huang Y., Singh S.V. Withaferin a suppresses estrogen receptor-alpha expression in human breast cancer cells. Mol. Carcinog. 2011, 50:614-624.
27. Hahm E.R., Moura M.B., Kelley E.E., Van Houten B., Shiva S., Singh S.V. Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species. PLoS One 2011, 6:e23354.
28. Holland W.L., Summers S.A. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr. Rev. 2008, 29:381-402.
29. Koduru S., Kumar R., Srinivasan S., Evers M.B., Damodaran C. Notch-1 inhibition by withaferin-A: a therapeutic target against colon carcinogenesis. Mol. Cancer Ther. 2010, 9:202-210.
30. Kornhuber J., Tripal P., Reichel M., Muhle C., Rhein C., Muehlbacher M., Groemer T.W., Gulbins E. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell. Physiol. Biochem. 2010, 26:9-20.
31. Kuebler W.M., Yang Y., Samapati R., Uhlig S. Vascular barrier regulation by PAF, ceramide, caveolae, and NO - an intricate signaling network with discrepant effects in the pulmonary and systemic vasculature. Cell. Physiol. Biochem. 2010, 26:29-40.
32. Lang E., Jilani K., Zelenak C., Pasham V., Bobbala D., Qadri S.M., Lang F. Stimulation of suicidal erythrocyte death by benzethonium. Cell. Physiol. Biochem. 2011, 28:347-354.
33. Lang F., Gulbins E., Lang P.A., Zappulla D., Foller M. Ceramide in suicidal death of erythrocytes. Cell. Physiol. Biochem. 2010, 26:21-28.
34. Lang F., Gulbins E., Lerche H., Huber S.M., Kempe D.S., Foller M. Eryptosis, a window to systemic disease. Cell. Physiol. Biochem. 2008, 22:373-380.
35. Lang P.A., Schenck M., Nicolay J.P., Becker J.U., Kempe D.S., Lupescu A., Koka S., Eisele K., Klarl B.A., Rubben H., Schmid K.W., Mann K., Hildenbrand S., Hefter H., Huber S.M., Wieder T., Erhardt A., Haussinger D., Gulbins E., Lang F. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat. Med. 2007, 13:164-170.
36. Lau, I.P., Chen, H., Wang, J., Ong, H.C., Leung, K.C., Ho, H.P., Kong, S.K., 2011. In vitro effect of CTAB- and PEG-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes. Nanotoxicology. http://dx.doi:10.3109/17435390.2011.625132.
37. Lee J., Hahm E.R., Singh S.V. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells. Carcinogenesis 2010, 31:1991-1998.
38. Lee T.J., Um H.J., Min D.S., Park J.W., Choi K.S., Kwon T.K. Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Free Radic. Biol Med. 2009, 46:1639-1649.
39. Li X., Becker K.A., Zhang Y. Ceramide in redox signaling and cardiovascular diseases. Cell. Physiol. Biochem. 2010, 26:41-48.
40. Maellaro, E., Leoncini, S., Moretti, D., Del Bello, B., Tanganelli, I., De Felice, C., Ciccoli, L., 2011. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol. doi:10.1007/s00592-011-0274-0.
41. Maitra R., Porter M.A., Huang S., Gilmour B.P. Inhibition of NFkappaB by the natural product withaferin A in cellular models of Cystic Fibrosis inflammation. J. Inflamm. (Lond) 2009, 6:15.
42. Malik F., Kumar A., Bhushan S., Khan S., Bhatia A., Suri K.A., Qazi G.N., Singh J. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis 2007, 12:2115-2133.
43. Mandal C., Dutta A., Mallick A., Chandra S., Misra L., Sangwan R.S., Mandal C. Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade. Apoptosis 2008, 13:1450-1464.
44. Mayola E., Gallerne C., Esposti D.D., Martel C., Pervaiz S., Larue L., Debuire B., Lemoine A., Brenner C., Lemaire C. Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2. Apoptosis 2011, 16:1014-1027.
45. Mirjalili M.H., Fakhr-Tabatabaei S.M., Alizadeh H., Ghassempour A., Mirzajani F. Genetic and withaferin A analysis of Iranian natural populations of Withania somnifera and W. coagulans by RAPD and HPTLC. Nat. Prod. Commun. 2009, 4:337-346.
46. Munagala R., Kausar H., Munjal C., Gupta R.C. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Carcinogenesis 2011, 32:1697-1705.
47. Oh J.H., Lee T.J., Kim S.H., Choi Y.H., Lee S.H., Lee J.M., Kim Y.H., Park J.W., Kwon T.K. Induction of apoptosis by withaferin A in human leukemia U937 cells through down-regulation of Akt phosphorylation. Apoptosis 2008, 13:1494-1504.
48. Park H.J., Rayalam S., Della-Fera M.A., Ambati S., Yang J.Y., Baile C.A. Withaferin A induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Biofactors 2008, 33:137-148.
49. Qadri S.M., Bauer J., Zelenak C., Mahmud H., Kucherenko Y., Lee S.H., Ferlinz K., Lang F. Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death. Cell. Physiol. Biochem. 2011, 28:339-346.
50. Qadri S.M., Kucherenko Y., Zelenak C., Jilani K., Lang E., Lang F. Dicoumarol Activates ca-permeable cation channels triggering erythrocyte cell membrane scrambling. Cell. Physiol. Biochem. 2011, 28:857-864.
51. Qadri S.M., Mahmud H., Lang E., Gu S., Bobbala D., Zelenak C., Jilani K., Siegfried A., Foller M., Lang F. Enhanced suicidal erythrocyte death in mice carrying a loss of function mutation of the Adenomatous Polyposis Coli gene 2011, J. Cell. Mol. Med.
52. ]i concentration in human erythrocytes incubated with lead. Toxicol. In Vitro 2010, 24:1338-1346.
53. Samadi A.K., Tong X., Mukerji R., Zhang H., Timmermann B.N., Cohen M.S. Withaferin A, a cytotoxic steroid from Vassobia breviflora, induces apoptosis in human head and neck squamous cell carcinoma. J Nat. Prod. 2010, 73:1476-1481.
54. Sen N., Banerjee B., Das B.B., Ganguly A., Sen T., Pramanik S., Mukhopadhyay S., Majumder H.K. Apoptosis is induced in leishmanial cells by a novel protein kinase inhibitor withaferin A and is facilitated by apoptotic topoisomerase I-DNA complex. Cell Death Differ. 2007, 14:358-367.
55. Siraskar B., Ballal A., Bobbala D., Foller M., Lang F. Effect of amphotericin B on parasitemia and survival of plasmodium berghei-infected mice. Cell. Physiol. Biochem. 2010, 26:347-354.
56. Srinivasan S., Ranga R.S., Burikhanov R., Han S.S., Chendil D. Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer Res. 2007, 67:246-253.
57. Stan S.D., Hahm E.R., Warin R., Singh S.V. Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Cancer Res. 2008, 68:7661-7669.
58. Thaiparambil J.T., Bender L., Ganesh T., Kline E., Patel P., Liu Y., Tighiouart M., Vertino P.M., Harvey R.D., Garcia A., Marcus A.I. Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. Int. J. Cancer 2011, 129:2744-2755.
59. Tong M., Neusner A., Longato L., Lawton M., Wands J.R., de la Monte S.M. Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease. J. Alzheimers Dis. 2009, 17:827-844.
60. Walter S., Fassbender K. Spingolipids in multiple sclerosis. Cell. Physiol. Biochem. 2010, 26:49-56.
61. Yang E.S., Choi M.J., Kim J.H., Choi K.S., Kwon T.K. Combination of withaferin A and X-ray irradiation enhances apoptosis in U937 cells. Toxicol. In Vitro 2011, 25:1803-1810.
62. Yang E.S., Choi M.J., Kim J.H., Choi K.S., Kwon T.K. Withaferin A enhances radiation-induced apoptosis in Caki cells through induction of reactive oxygen species, Bcl-2 downregulation and Akt inhibition. Chem. Biol. Interact. 2011, 190:9-15.
63. Yang H., Shi G., Dou Q.P. The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from " Indian winter cherry" Mol. Pharmacol. 2007, 71:426-437.
64. Yu Y., Hamza A., Zhang T., Gu M., Zou P., Newman B., Li Y., Gunatilaka A.A., Zhan C.G., Sun D. Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochem. Pharmacol. 2010, 79:542-551.
65. Zappulla D. Environmental stress, erythrocyte dysfunctions, inflammation, and the metabolic syndrome: adaptations to CO2 increases?. J. Cardiometab. Syndr. 2008, 3:30-34.
66. Zelenak C., Eberhard M., Jilani K., Qadri S.M., Macek B., Lang F. Protein kinase CK1alpha regulates erythrocyte survival. Cell. Physiol. Biochem. 2012, 29:171-180.
67. Zhang X., Mukerji R., Samadi A.K., Cohen M.S. Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells. BMC Complement. Altern. Med. 2011, 11:84.
68. Zhang X., Samadi A.K., Roby K.F., Timmermann B., Cohen M.S. Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A. Gynecol. Oncol. 2012, 124:606-612.
69. Zhao H., Przybylska M., Wu I.H., Zhang J., Siegel C., Komarnitsky S., Yew N.S., Cheng S.H. Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes. Diabetes 2007, 56:1210-1218.
70. Zigmond E., Zangen S.W., Pappo O., Sklair-Levy M., Lalazar G., Zolotaryova L., Raz I., Ilan Y. Beta-glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E72-E78.
71. Zwaal R.F., Comfurius P., Bevers E.M. Surface exposure of phosphatidylserine in pathological cells. Cell. Mol. Life Sci. 2005, 62:971-988.